PL364411A1 - Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego - Google Patents

Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego

Info

Publication number
PL364411A1
PL364411A1 PL04364411A PL36441104A PL364411A1 PL 364411 A1 PL364411 A1 PL 364411A1 PL 04364411 A PL04364411 A PL 04364411A PL 36441104 A PL36441104 A PL 36441104A PL 364411 A1 PL364411 A1 PL 364411A1
Authority
PL
Poland
Prior art keywords
formulation
extract
metabolic syndrome
treating obesity
associated metabolic
Prior art date
Application number
PL04364411A
Other languages
English (en)
Other versions
PL209905B1 (pl
Inventor
Marcin Krotkiewski
Original Assignee
Bringwell International Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bringwell International Ab filed Critical Bringwell International Ab
Priority to PL364411A priority Critical patent/PL209905B1/pl
Priority to KR1020067016137A priority patent/KR100826863B1/ko
Priority to AU2005205031A priority patent/AU2005205031A1/en
Priority to US10/585,546 priority patent/US20090175969A1/en
Priority to PCT/EP2005/000206 priority patent/WO2005067952A1/en
Priority to RU2006129486/15A priority patent/RU2334523C2/ru
Priority to CA002584191A priority patent/CA2584191A1/en
Priority to DE602005010387T priority patent/DE602005010387D1/de
Priority to JP2006548251A priority patent/JP2007517830A/ja
Priority to CNA2005800024043A priority patent/CN1946415A/zh
Priority to AT05700833T priority patent/ATE411033T1/de
Priority to EP05700833A priority patent/EP1708726B1/en
Publication of PL364411A1 publication Critical patent/PL364411A1/pl
Priority to NO20063655A priority patent/NO20063655L/no
Publication of PL209905B1 publication Critical patent/PL209905B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL364411A 2004-01-15 2004-01-15 Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego PL209905B1 (pl)

Priority Applications (13)

Application Number Priority Date Filing Date Title
PL364411A PL209905B1 (pl) 2004-01-15 2004-01-15 Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego
DE602005010387T DE602005010387D1 (de) 2004-01-15 2005-01-12 Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom
JP2006548251A JP2007517830A (ja) 2004-01-15 2005-01-12 肥満及びそれに関連するメタボリックシンドロームを治療するための製剤
US10/585,546 US20090175969A1 (en) 2004-01-15 2005-01-12 Formulation for treating obesity and associated metabolic syndrome
PCT/EP2005/000206 WO2005067952A1 (en) 2004-01-15 2005-01-12 Formulation for treating obesity and associated metabolic syndrome
RU2006129486/15A RU2334523C2 (ru) 2004-01-15 2005-01-12 Композиции для лечения ожирения и ассоциированного метаболического синдрома
CA002584191A CA2584191A1 (en) 2004-01-15 2005-01-12 Formulation for treating obesity and associated metabolic syndrome
KR1020067016137A KR100826863B1 (ko) 2004-01-15 2005-01-12 비만 및 관련 대사 증후군 치료용 제제
AU2005205031A AU2005205031A1 (en) 2004-01-15 2005-01-12 Formulation for treating obesity and associated metabolic syndrome
CNA2005800024043A CN1946415A (zh) 2004-01-15 2005-01-12 治疗肥胖症及相关代谢综合征的制剂
AT05700833T ATE411033T1 (de) 2004-01-15 2005-01-12 Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom
EP05700833A EP1708726B1 (en) 2004-01-15 2005-01-12 Formulation for treating obesity and associated metabolic syndrome
NO20063655A NO20063655L (no) 2004-01-15 2006-08-14 Formulering for behandling av fedme og assosiert metabolisk syndrom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL364411A PL209905B1 (pl) 2004-01-15 2004-01-15 Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego

Publications (2)

Publication Number Publication Date
PL364411A1 true PL364411A1 (pl) 2005-07-25
PL209905B1 PL209905B1 (pl) 2011-11-30

Family

ID=34793496

Family Applications (1)

Application Number Title Priority Date Filing Date
PL364411A PL209905B1 (pl) 2004-01-15 2004-01-15 Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego

Country Status (13)

Country Link
US (1) US20090175969A1 (pl)
EP (1) EP1708726B1 (pl)
JP (1) JP2007517830A (pl)
KR (1) KR100826863B1 (pl)
CN (1) CN1946415A (pl)
AT (1) ATE411033T1 (pl)
AU (1) AU2005205031A1 (pl)
CA (1) CA2584191A1 (pl)
DE (1) DE602005010387D1 (pl)
NO (1) NO20063655L (pl)
PL (1) PL209905B1 (pl)
RU (1) RU2334523C2 (pl)
WO (1) WO2005067952A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2883472B1 (fr) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale Utilisation d'un acide chlorogenique en tant qu'un actif amincissant
GB0520956D0 (en) 2005-10-14 2005-11-23 Med Eq As Chewing gum
AU2006311892B2 (en) 2005-11-04 2012-06-21 Inqpharm Group Sdn. Bhd. Herbal composition for weight management
KR20090003281A (ko) * 2006-03-31 2009-01-09 디에스엠 아이피 어셋츠 비.브이. 신체적 외관의 개선을 위한 화합물 및 화합물의 조합물의 신규한 용도
US20110071107A1 (en) 2006-10-20 2011-03-24 Stephanie K Lynch Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
CA2686419A1 (en) * 2007-05-04 2008-11-13 Nutraceutic Et Business Consulting Composition having lipolytic activity, production method thereof and use of the composition
KR20110066951A (ko) * 2008-10-03 2011-06-17 시그마 알리멘토스, 에스.에이. 데 씨. 브이. 총 및 ｌｄｌ 콜레스테롤의 제어 및/또는 체중 감량 및/또는 열발생을 촉진하기 위한 조성물
RU2465787C1 (ru) * 2008-10-03 2012-11-10 СИГМА АЛИМЕНТОС, С.А. де К.В. Композиция, способствующая регуляции общего холестерина и холестерина лпнп, и/или потере веса, и/или термогенезу
FR2938735B1 (fr) * 2008-11-21 2012-12-28 Holymark Composition amaigrissante, en particulier pour sportifs, administrable par voie orale et complement alimentaire integrant une telle composition.
KR20100124519A (ko) * 2009-05-19 2010-11-29 (주)아모레퍼시픽 녹차 추출물을 함유하는 조성물
CN102370589B (zh) * 2010-08-11 2013-02-13 迪特克(济源)绿色生物科技有限公司 一种减肥霜及其制备方法
KR101719436B1 (ko) 2011-01-21 2017-03-23 라이온 가부시키가이샤 지방 분해 촉진 조성물
US20130177506A1 (en) * 2011-10-27 2013-07-11 Parker E. Atkins Bio-Available Chlorogenic Acid Preparations for Supplemental Human Consumption and Use
DE102014100534A1 (de) * 2014-01-17 2015-07-23 Pm-International Ag Pulverförmige Zusammensetzung zur Herstellung eines Nahrungsmittelersatzes
AU2016253140B2 (en) * 2015-04-24 2019-04-18 Tru-Science, Llc Plant extracts for the treatment of excess weight and obesity
CN107302997A (zh) * 2016-04-19 2017-10-31 林秀霞 一种抑制脂肪蓄积的组合物及其用途
CN107638569A (zh) * 2016-07-21 2018-01-30 上海聿健生物科技有限公司 增强褐色脂肪细胞产热效率的方法和应用
WO2018175417A1 (en) * 2017-03-21 2018-09-27 Pharmachem Laboratories, Llc Controlled release of phaseolamin compositions
US11738061B2 (en) * 2018-03-05 2023-08-29 Pure Care Pro Llc Natural combination products and methods for regulation of kidney and excretory system function
KR102267472B1 (ko) * 2018-10-24 2021-06-21 전남대학교산학협력단 녹차 카테킨을 포함하는 중성지방 저감용 식품 조성물, 대사성 질환 개선용 식품 조성물 및 대사성 질환 예방 또는 치료용 약학 조성물
CN113116955B (zh) * 2021-02-24 2022-10-04 中国药科大学 一种含植物提取物的药物组合物及其应用
JP2024008717A (ja) * 2022-07-08 2024-01-19 株式会社常磐植物化学研究所 カフェイン除去マテ抽出物、抗肥満用組成物、カフェイン除去方法及びマテ抽出物の製造方法
KR20240011314A (ko) 2022-07-19 2024-01-26 대구한의대학교산학협력단 과라나 추출물을 포함하는 지방 분화 유도 억제, 지방 합성 억제 및 혈장 콜레스테롤 생성 억제용 조성물, 약학 조성물 및 건강기능식품

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
FR2712191B1 (fr) * 1993-11-08 1996-03-08 Bioes Laboratoires Composition pharmaceutique ou diététique associant du ginseng et du guarana.
US5804596A (en) * 1997-02-27 1998-09-08 Sabinsa Corporation Method of preparing a forskohlin composition from forskohlin extract and use of forskohlin for promoting lean body mass and treating mood disorders
JPH10265328A (ja) * 1997-03-27 1998-10-06 Nippon Flour Mills Co Ltd 化粧料、ペットフード、リパーゼ阻害剤及びそれを含む食品
US6143301A (en) * 1998-08-28 2000-11-07 Ambi Inc. Chromium picolinate compositions and uses thereof
JP4783882B2 (ja) * 1999-11-17 2011-09-28 三邦株式会社 新規α−アミラーゼ阻害活性物質、その製造方法及びその用途
US6610749B2 (en) * 2000-02-18 2003-08-26 Arch Development Corporation Polyhydroxylated benzene-containing compounds
PT1272154E (pt) * 2000-04-04 2004-11-30 Color Access Inc Composicao para melhorar a funcao da barreira lipidica da pele
JP4795511B2 (ja) * 2000-07-14 2011-10-19 日本サプリメント株式会社 α−グルコシダーゼ阻害剤の製造法
US6797287B2 (en) * 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
AU2003218834A1 (en) * 2002-03-11 2003-09-22 General Nutrition Investment Company Methods for the treatment and prevention of overweight in mammals
US7279184B2 (en) * 2003-10-24 2007-10-09 Herbalscience, Llc Methods and compositions comprising Ilex

Also Published As

Publication number Publication date
AU2005205031A1 (en) 2005-07-28
KR100826863B1 (ko) 2008-05-06
EP1708726A1 (en) 2006-10-11
ATE411033T1 (de) 2008-10-15
CA2584191A1 (en) 2005-07-28
PL209905B1 (pl) 2011-11-30
WO2005067952A1 (en) 2005-07-28
EP1708726B1 (en) 2008-10-15
CN1946415A (zh) 2007-04-11
RU2334523C2 (ru) 2008-09-27
JP2007517830A (ja) 2007-07-05
US20090175969A1 (en) 2009-07-09
WO2005067952A8 (en) 2005-11-03
NO20063655L (no) 2006-09-22
DE602005010387D1 (de) 2008-11-27
KR20070009562A (ko) 2007-01-18
RU2006129486A (ru) 2008-02-20

Similar Documents

Publication Publication Date Title
ATE411033T1 (de) Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom
GB2435166B (en) High molecular weight polphenols extracted from fermented tea and a method of manufacturing a medicament for the prevention and treatment of diabetes
EP3444242A3 (en) Novel benzopyran kinase modulators
HK1146485A1 (pl)
WO2009001362A3 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
WO2009032888A3 (en) Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract
IL179012A (en) A drug containing cetirizine for the treatment of nasal inflammation, a process for its preparation and use
UA100542C2 (ru) Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba
IL196788A0 (en) New eucalyptus extract, method of preparation and therapeutic uses thereof
WO2007104780A3 (en) N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use
WO2007056133A3 (en) Herbal composition for weight management
EP2215070A4 (en) NEW 1,3-DIHYDRO-5-ISOBENZOFURANCARA ACID ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF PREMATURE EJACULATION
EP1770090A4 (en) TEA POLYPHENOL COMPOSITION AND CORRESPONDING PRODUCTION PROCESS
WO2007128924A3 (fr) Extrait aqueux de feuilles de tabac , ses utilisations dans le traitement de la dependance
PH12014501823A1 (en) Pharmaceutical composition for treating urinary incontinence and enuresis
WO2008130321A3 (en) Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
EP1784199A4 (en) COMPOUNDS FOR TREATING MARIHUANA DEPENDENCE, DEDUCTION AND CONSUMPTION
WO2010072774A3 (de) 5-ht2a und 5-ht2b rezeptorantagonisten zur behandlung der spinalkanalstenose
TW200610532A (en) Anti-stress composition
PL1962822T3 (pl) Terapia nowotworów złośliwych
WO2008110603A3 (en) Concentrate of protein c containing protein s, its preparation and use
WO2010069621A8 (en) Treatment of vaginal atrophy in women with cardiovascular pathology risk
WO2007033356A3 (en) Compositions and methods for green tea catechins for modification of detoxification enzymes
WO2008145838A3 (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
WO2008084762A1 (ja) テアニン含有神経細胞新生促進組成物

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120115